With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Atlanta-based Northside Hospital has treated its first patient using Medtronic's PulseSelect pulsed field ablation system for treating paroxysmal or persistent atrial fibrillation. The device, which ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Medtronic has reported revenue gains across several of its medical device franchises, leading the company to ... aortic valve ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.

Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.

Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...